- Home
- MHN vs CADL Comparison
MHN vs CADL Comparison
Compare MHN & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHN
- CADL
- Stock Information
- Founded
- MHN 1997
- CADL 1999
- Country
- MHN United States
- CADL United States
- Employees
- MHN N/A
- CADL N/A
- Industry
- MHN Investment Bankers/Brokers/Service
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- MHN Finance
- CADL Health Care
- Exchange
- MHN Nasdaq
- CADL Nasdaq
- Market Cap
- MHN N/A
- CADL 234.8M
- IPO Year
- MHN N/A
- CADL 2021
- Fundamental
- Price
- MHN $10.02
- CADL $4.76
- Analyst Decision
- MHN
- CADL Strong Buy
- Analyst Count
- MHN 0
- CADL 4
- Target Price
- MHN N/A
- CADL $21.00
- AVG Volume (30 Days)
- MHN 59.2K
- CADL 864.6K
- Earning Date
- MHN 01-01-0001
- CADL 05-13-2025
- Dividend Yield
- MHN 4.17%
- CADL N/A
- EPS Growth
- MHN N/A
- CADL N/A
- EPS
- MHN N/A
- CADL N/A
- Revenue
- MHN N/A
- CADL N/A
- Revenue This Year
- MHN N/A
- CADL N/A
- Revenue Next Year
- MHN N/A
- CADL N/A
- P/E Ratio
- MHN N/A
- CADL N/A
- Revenue Growth
- MHN N/A
- CADL N/A
- 52 Week Low
- MHN $8.69
- CADL $3.79
- 52 Week High
- MHN $10.81
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- MHN 53.46
- CADL 41.42
- Support Level
- MHN $9.95
- CADL $4.80
- Resistance Level
- MHN $10.09
- CADL $5.34
- Average True Range (ATR)
- MHN 0.11
- CADL 0.33
- MACD
- MHN 0.04
- CADL 0.10
- Stochastic Oscillator
- MHN 87.27
- CADL 42.09
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.